Home › Alcohol Use Disorder (AUD) › NCT07342504

Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment

Better Experiences in Substance Treatment: A Brief Alcohol-Focused Intervention Tailored for Patients in Opioid Agonist Treatment

Who can join

Ages 18 and older · All sexes

Inclusion Criteria for the RCT:

* Participants must be taking prescribed buprenorphine for at least 2 weeks
* Participants must be 18 years or older.
* Meet DSM-5 criteria for alcohol use disorder (AUD)
* Participants must report alcohol use ≥ 1 day/week on average in the past 28 days
* Participants must be able to read simple English

Exclusion Criteria:

* Currently receiving formal alcohol use treatment.
* Currently experiencing psychosis

About the study

This study will help determine the feasibility and acceptability of a brief opioid-informed alcohol intervention in patients receiving prescribed buprenorphine for opioid use who are currently drinking alcohol. It will also provide initial information on whether the intervention improves outcomes related to alcohol use. The results of this proof-of-concept study will inform whether a future larger clinical trial is warranted.

What is being tested

• Brief opioid-informed alcohol treatment (behavioral)

Sponsor: University of Notre Dame · Participants: 60 · Started: Mar 24, 2026

Contact the study team

• Ryan Carpenter, PhD · Phone: +1 574-631-5429
• Beth A Arnold, M.S. · Phone: 574-213-2096

Official record on ClinicalTrials.gov — NCT07342504

Locations in the U.S.

Conditions

• Alcohol Use Disorder (AUD)
• Opioid Overdose
• Alcohol

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.